Form 8-K
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 17, 2009

MIMEDX GROUP, INC.
(Exact name of registrant as specified in its charter)

         
Florida   000-52491   26-2792552
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
811 Livingston Court, Suite B
Marietta, GA
  30067
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (678) 384-6720

 
 
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1


 

Section 7 – Regulation FD

Item 7.01   Regulation FD Disclosure

On November 17, 2009, the Chairman and Chief Executive Officer of the Company issued a letter to shareholders. The letter will be available on the Company’s website, www.mimedxgroup.com, and is attached hereto as Exhibit 99.1.

Section 9 – Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

  Exhibit 99.1    Letter from the Chairman and Chief Executive Officer dated November 17, 2009, furnished pursuant to Item 7.01.

2

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
  MIMEDX GROUP, INC.
 
Dated: November 17, 2009 By: /s/ Michael J. Culumber
    Michael J. Culumber, Chief Financial Officer

3

 

3


 

EXHIBIT INDEX

     
Exhibit
Number
  Description
Exhibit 99.1    Letter from the Chairman and Chief Executive Officer dated November 17, 2009, furnished pursuant to Item 7.01.

4

 

4